Document:

dvax-ex1033_133.htm

 

			
	

	
 
	
Exhibit 10.33

 

 

December 14, 2020 

 

 

Kelly MacDonald

 

Subject: Offer Letter 

 

Dear Kelly:

 

Dynavax Technologies is pleased to offer you the position of Senior Vice President, Chief Financial Officer, on the terms outlined below.  We are excited that you will be joining our team of dedicated and talented professionals focused on investigating, developing and commercializing innovative vaccines to provide protection for an unpredictable world.

 

As our CFO, you will report to Ryan Spencer, CEO, and work at our facility located at 2100 Powell Street, Suite 900 in Emeryville, California. The Company may change your position, duties, manager, and work location from time to time as it deems necessary. 

 

Our offer of employment is contingent upon your appointment as CFO by the Dynavax Board of Directors.  

 

COMPENSATION & BENEFITS

Your compensation will be $31,250.00 per month, annualized to $375,000.00, less payroll deductions and all required withholdings.  You will be paid semi-monthly on the 15th of each month and on the last day of each month.  You will be eligible to participate in the Company’s standard benefit programs including medical, dental, and vision insurance programs for yourself and your qualified dependents beginning on your first day of employment.  There will be an employee contribution for these coverages. Dynavax offers up to 13 company paid holidays per year, life insurance, disability insurance, long-term care insurance, Flexible Spending Account, 401(k) match, and Employee Stock Purchase Plan.  The Company may modify compensation and benefits from time to time as it deems necessary.

 

As a Director and above level employee, you will be eligible for our “Non-accrual Vacation Policy for Director & Above Employees”. A copy of the policy will be sent to you under separate cover.

 

BONUS

You are eligible to participate in the Company's Bonus Plan with a target incentive of 50% of your annual base salary.  Your annual cash incentive is 20% based on your individual performance and 80% of the corporate goals. Payment of the Company's Bonus Plan is determined based on your individual performance (including the accomplishment of individual goals) and the Company's accomplishment of approved corporate goals.  The payout of the Company’s Bonus Plan is at the discretion of the Dynavax Board of Directors.  Employees who join the company between January 1st and on the first business day in October of such performance year, will be eligible for prorated annual compensation awards (bonus, merit, and annual equity grant) for their first year of employment.  Employees hired after the first business day in October will be eligible to participate in our annual compensation awards the following year.

2100 Powell Street, Suite 900, Emeryville, California 94608

 

							
	
 
	
 
	
 
	
 
	
 
	
 
	
 

	
Phone: 510-848-5100
	
 
	
Toll-Free: 877-848-5100
	
 
	
Fax: 510-848-1327
	
 
	
www.dynavax.com

 

 

			
	
 
	
 
	

 

 

 

STOCK OPTIONS

The Company will grant you a stock option to purchase 350,000 shares of the Common Stock of the Company, with an exercise price equal to the closing price of the Common Stock on the date your first day of employment with Dynavax.  Your new hire equity grant will be comprised of NQ stock options issued from our inducement pool.  This stock option is subject to all of the terms and conditions set forth in the applicable award agreement and applicable stock incentive plan. Your stock option grant of 350,000 shares of the Common Stock of the Company will vest as follows: one-third (1/3) of the Shares subject to the Option shall vest twelve months after the Vesting Commencement Date, and 1/36 of the Shares subject to the Option shall vest on the last day of each month, provided that vesting shall cease upon termination of your continuous service to the Company.

 

SIGN-ON BONUS

You will receive a $15,000 sign-on bonus, less applicable withholding deductions that will be paid in the pay cycle after completing 30-days of full-time employment.  If you voluntarily terminate your employment within 12-months of your start date, this amount must be reimbursed to the Company.

 

RELOCATION BENEFITS

Your relocation package will be paid by Dynavax and will include the following benefits:

	
 
	
•
	
Pack and move usual and customary household goods from Boston, MA to your residence in San Francisco, CA.

	
 
	
•
	
Ship and un-pack stored household goods at your residence in San Francisco, CA. 

	
 
	
•
	
Move up to two automobiles from Boston, MA to San Francisco, CA.
	
 

	
 
	
•
	
One-way trip to relocate you and your immediate family including your pet(s) to San Francisco, CA.
	
 

	
 
	
o
	
Economy Plus Class (or equivalent class) airfare arranged through Dynavax’s travel agent in accordance with the company’s travel and expense policy.
	
 

 

If you voluntarily terminate your employment within 12-months of your start date, you must reimburse Dynavax for all relocation expenses that Dynavax paid for or reimbursed you for in connection with your relocation.

 

The relocation benefits eligible under the IRS will be grossed up to cover appropriate withholding deductions.

 

OTHER AGREEMENTS 

As a Senior Vice President, you will receive our Management Continuity and Severance Agreement (MCSA) at the benefit levels as approved by the Compensation Committee and defined in the agreement.  In addition, you will receive our standard Indemnity Agreement.  Copies of these agreements will be delivered to you as soon as administratively possible after your first day of employment.  

 

EMPLOYMENT VERIFICATION & BACKGROUND CHECK

This offer is subject to your submission of a completed and signed I-9 form within 3 days of your employment, along with satisfactory documentation(s) verifying your identification and right to work in the United States.  

 

Your employment is also contingent upon the acceptable results of reference checks, and background checks, including but not limited to your Social Security number, education, employment, FACIS (Fraud and Abuse Control Information System), credit check, and criminal verification (including the 50-state sex offender database). Any falsification in your employment history, educational and criminal background will result in withdrawal of the offer, or termination of employment, if hired.

2

 

 

			
	
 
	
 
	

 

 

 

COMPANY POLICY & PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT

As an employee of the Company, you will be expected to abide by Company rules and regulations as well as the Dynavax Code of Business Conduct and Ethics, and to sign and comply with a Proprietary Information and Inventions Agreement, which prohibits unauthorized use or disclosure of the Company's proprietary information.

 

WORKING HOURS

Normal working hours are from 8:00 a.m. to 5:00 p.m., Monday through Friday.  As an exempt salaried employee, you will be expected to work additional hours as required by the nature of your work assignments.

 

AT-WILL EMPLOYMENT

You may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying the Company.  Likewise, the Company may terminate your employment at any time and for any reason whatsoever, with or without cause or advanced notice.  This at-will employment relationship cannot be changed except by written agreement signed by a Company officer.

 

The employment terms in this letter and your Management Continuity and Severance Agreement (MCSA) supersede any other agreements or promises made to you by anyone, whether oral or written.  

 

Please sign and date this letter and return it via DocuSign to Human Resources by Friday, December 18, 2020, if you wish to accept employment with Dynavax under the terms described above. If you accept our offer, we would like you to start no later than March 1, 2021.

 

Kelly, we look forward to a favorable reply and to a productive and enjoyable work relationship.

 

 

Sincerely,

 

/s/ RYAN SPENCER

 

Ryan Spencer

CEO 

 

 

Accepted:

 

 

			
	
/s/ KELLY MACDONALD
	
 
	
12/15/2020

	
Kelly MacDonald
	
 
	
Date

 

3Document

DESCRIPTION OF CAPITAL STOCK OF ADT INC.
REGISTERED PURSUANT TO SECTION 12 OF THE
SECURITIES EXCHANGE ACT OF 1934
As of December 31, 2020, ADT Inc. (the “company,” “we,” “us” and “our”) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Act”): common stock, par value $0.01 per share. We also have class B common stock, par value $0.01 per share, which is not registered under Section 12 of the Act.  The following description of ADT’s capital stock summarizes certain provisions of our amended and restated certificate of incorporation (the “Certificate of Incorporation”) and our amended and restated bylaws (the “Bylaws”). The description is intended as a summary, and is qualified in its entirety by reference to our Certificate of Incorporation and our Bylaws, copies of which have been filed as exhibits to this Annual Report on Form 10-K. 
References to “Apollo” and the “Sponsor” refer to certain investment funds directly or indirectly managed by affiliates of Apollo Global Management Inc., their subsidiaries and their affiliates. References to “Ultimate Parent” refer to Prime Security Services TopCo Parent, LP, our direct parent company. Defined terms used herein, but otherwise not defined, shall have the meaning ascribed to them in this Annual Report on Form 10-K.
General 
Pursuant to our Certificate of Incorporation, our capital stock consists of 4,100,000,000 authorized shares, of which 3,999,000,000 shares are designated as “common stock”, 100,000,000 shares are designated as “Class B common stock” and 1,000,000 shares, par value $0.01 per share, are designated as “preferred stock”. As of December 31, 2020, we had 770,433,609 shares of common stock issued and outstanding. Shares of common stock and Class B common stock shall have the same rights and privileges and rank equally, share ratably, and be identical in all respects as to all matters. 
Common Stock 
Voting Rights. Except as otherwise required by applicable law or our Certificate of Incorporation, the holders of our common stock are entitled to one vote per share on all matters submitted to a vote of our stockholders generally. 
Dividend Rights. Subject to applicable law and the rights of holders of any outstanding series of preferred stock, all shares of our common stock are entitled to share equally in any dividends our board of directors may declare from legally available sources. The common stock and the Class B common stock have the same rights and privileges and rank equally, share ratably, and are identical in all respects with respect to dividend rights; provided, however, that in the event that a dividend is paid in the form of shares of common stock, Class B common stock or rights to acquire common stock and Class B common stock, the holders of common stock shall receive common stock or rights to acquire common stock, as the case may be, and the holders of Class B common stock shall receive an equal number of shares on a per share basis, of Class B common stock or rights to acquire Class B common stock, as the case may be.
Liquidation Rights. Upon our liquidation, dissolution or winding up, whether voluntary or involuntary, after payment or provision of any of our debts and other liabilities, and subject to the rights of any holders of any outstanding series of preferred stock, all shares of our common stock are entitled to share equally in the assets available for distribution to stockholders. The common stock and the Class B common stock have the same rights and privileges and rank equally, share ratably, and are identical in all respects with respect to liquidation rights.
Other Matters. Holders of our common stock have no preemptive or conversion rights, and our common stock is not subject to further calls or assessments by us, except with respect to common stock 

Doc#: US1:13557525v6

2

issued in connection with the exercise of options issued pursuant to our 2016 Equity Incentive Plan, which is subject to a call right by our Sponsor. 
Class B Common Stock
Voting Rights. Except as otherwise required by applicable law or the Certificate of Incorporation, the holders of our Class B common stock are entitled to one vote per share on all matters submitted to a vote of our stockholders generally, except holders of Class B common stock shall not be entitled to vote on the election, appointment or removal of directors of the Company.
Dividend Rights. Subject to applicable law and the rights of holders of any outstanding series of preferred stock, all shares of our Class B common stock are entitled to share equally in any dividends the board of directors may declare from legally available sources. The common stock and the Class B common stock have the same rights and privileges and rank equally, share ratably, and are identical in all respects with respect to dividend rights; provided, however, that in the event that a dividend is paid in the form of shares of common stock, Class B common stock or rights to acquire common stock and Class B common stock, the holders of common stock shall receive common stock or rights to acquire common stock, as the case may be, and the holders of Class B common stock shall receive an equal number of shares on a per share basis, of Class B common stock or rights to acquire Class B common stock, as the case may be.
Liquidation Rights. Upon our liquidation, dissolution or winding up, whether voluntary or involuntary, after payment or provision of any of our debts and other liabilities, and subject to the rights of any holders of any outstanding series of preferred stock, all shares of our Class B common stock are entitled to share equally in the assets available for distribution to stockholders. The common stock and the Class B common stock have the same rights and privileges and rank equally, share ratably, and are identical in all respects with respect to liquidation rights.
Conversion Right. Holders of our Class B common stock are entitled to convert their shares of Class B common stock into common stock following the earlier of (x) the expiration or early termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR Clearance”), prior to such holder’s conversion of all such shares of Class B common stock, and (y) to the extent HSR Clearance is not required prior to such holder’s conversion of such shares of Class B common stock, the date that such holder owns such shares of Class B common stock.
Other Matters. Holders of our Class B common stock have no preemptive rights, and our Class B common stock is not subject to further calls or assessments by us.
Preferred Stock 
Pursuant to our Certificate of Incorporation, our board of directors is authorized, by resolution or resolutions, to provide, out of the authorized but unissued shares of preferred stock, for the issuance from time to time of shares of preferred stock in one or more series and, by filing a certificate of designation with the Secretary of State of the State of Delaware in accordance with the DGCL, to establish the number of shares to be included in each such series and the powers (including voting powers, if any), designations, preferences and relative, participating, optional or other special rights (if any), and any qualifications, limitations or restrictions thereof, of each series as our board of directors from time to time may adopt by resolution. Each series of preferred stock will consist of an authorized number of shares as will be stated and expressed in the certificate of designations providing for the creation of the series. 

Doc#: US1:13557525v6

3

Warrants 
Warrants were issued pursuant to a warrant agreement in connection with the acquisition of Cell Bounce and will vest in three equal tranches each consisting of 666,667 warrants, subject to certain performance criteria as described in the warrant agreement. Assuming that all warrants will vest in full, the warrants will be exercisable for 2,000,000 shares of common stock. The exercise price per whole share of common stock purchasable upon exercise of the warrants is $7.77 per share of common stock. We do not intend to list the warrants on any securities exchange or nationally recognized trading system. 
Composition of Board of Directors; Election and Removal of Directors 
In accordance with our Certificate of Incorporation and our Bylaws, the number of directors comprising our board of directors is determined from time to time exclusively by our board of directors; provided that the number of directors shall not exceed fifteen (15). 
 
Currently, the total number of directors constituting the board of directors is eleven. Our certificate of incorporation provides for a board of directors divided into three classes (each as nearly as equal as possible and with directors in each class serving staggered three-year terms), consisting of four directors in Class I (currently Messrs. DeVries, Ryan, Solomon and Ms. Griffin), four directors in Class II (currently Messrs. Press, Nord, Africk and Winter) and three directors in Class III (currently Messrs. Rayman, Becker and Ms. Drescher). See “—Certain Corporate Anti-takeover Provisions—Classified Board of Directors.” Under our Stockholders Agreement, Ultimate Parent has the right, but not the obligation, to nominate (a) a majority of our directors, as long as our Sponsor beneficially owns 50% or more of our outstanding common stock, (b) 50% of our directors, as long as our Sponsor beneficially owns 40% or more, but less than 50% of our outstanding common stock, (c) 40% of our directors, as long as our Sponsor beneficially owns 30% or more, but less than 40% of our outstanding common stock, (d) 30% of our directors, as long as our Sponsor beneficially owns 20% or more, but less than 30% of our outstanding common stock, and (e) 20% of our directors, as long as our Sponsor beneficially owns 5% or more, but less than 20% of our outstanding common stock. 
In connection with the acquisition of The ADT Security Corporation (formerly named The ADT Corporation) in May 2016, funds affiliated with or managed by Apollo and certain other investors in our indirect parent entities (the “Co-Investors”) received certain rights, including the right of three Co-Investors to designate one person to serve as a director (such director, the “Co-Investor Designee”) as long as such Co-Investor’s ownership exceeds a specified threshold. Two such Co-Investor Designees resigned from our board of directors on November 14, 2017 and December 19, 2017, respectively, and their respective Co-Investors subsequently executed waiver letters whereby they each waive all rights to designate an individual to serve as a director. Currently, only one Co-Investor has the right to designate a Co-Investor Designee. Under the Stockholders Agreement, Ultimate Parent has the right, but not the obligation, to nominate the Co-Investor Designee to serve as members of our board of directors. Ultimate Parent’s right to nominate the Co-Investor Designee is in addition to Ultimate Parent’s right to nominate a specified percentage of the directors based on the percentage of our outstanding common stock beneficially owned by the Sponsor, as described above. We refer to the directors nominated by Ultimate Parent at the direction of our Sponsor based on such percentage ownership as the “Apollo Designees” and we refer to the Co-Investor Designee and the Apollo Designees collectively as the “Sponsor Directors.” 
Each director is to hold office for a three year term and until the annual meeting of stockholders for the election of the class of directors to which such director has been elected and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal. Any vacancy on our board of directors (other than in respect of a Sponsor Director) will be filled only by the affirmative vote of a majority of the remaining directors, although less than a quorum. Any vacancy on our board of directors in respect of an Apollo Designee will be filled only by a majority of the Apollo Designees then in office or, if there are no such directors then in office, our Sponsor. Any vacancy on our board of directors in respect of the Co-Investor Designee will be filled only by a majority of the Sponsor Directors then in office or, if 

Doc#: US1:13557525v6

4

there are no such directors then in office, our Sponsor. Under our Certificate of Incorporation, stockholders do not have the right to cumulative votes in the election of directors. At any meeting of our board of directors, except as otherwise required by law, a majority of the total number of directors then in office will constitute a quorum for all purposes, except that if funds affiliated with or managed by Apollo own any shares of our common stock and there is at least one member of our board of directors who is an Apollo representative, then that representative must be present for there to be a quorum unless each Apollo representative waives his or her right to be included in the quorum at such meeting. 
Certain Corporate Anti-takeover Provisions 
Certain provisions in our Certificate of Incorporation and Bylaws summarized below may be deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider to be in its best interests, including attempts that might result in a premium being paid over the market price for the shares held by stockholders. 
Preferred Stock 
Our Certificate of Incorporation contains provisions that permit our board of directors to issue, without any further vote or action by stockholders, shares of preferred stock in one or more series and, with respect to each such series, to fix the number of shares constituting the series and the designation of the series, the voting rights (if any) of the shares of the series, and the powers, preference and relative, participation, optional and other special rights, if any, and any qualifications, limitations or restrictions, of the shares of such series. 
Classified Board of Directors 
Our Certificate of Incorporation provides that our board of directors is divided into three classes of directors, with the classes as nearly equal in number as possible, and with the directors in each class serving staggered three-year terms. As a result, approximately one-third of our board of directors is elected each year. The classification of directors has the effect of making it more difficult for stockholders to change the composition of our board of directors. Our Certificate of Incorporation provides that, subject to any rights of holders of preferred stock to elect additional directors under specified circumstances, the number of directors will be fixed from time to time exclusively pursuant to a resolution adopted by our board of directors, as described above in “—Composition of Board of Directors; Election and Removal of Directors.” 
Removal of Directors; Vacancies 
Under the DGCL, unless otherwise provided in our Certificate of Incorporation, directors serving on a classified board may be removed by the stockholders only for cause. Our Certificate of Incorporation provides that directors may be removed with or without cause upon the affirmative vote of a majority in voting power of all outstanding shares of stock entitled to vote thereon, voting together as a single class; provided, however, that from and after the time Apollo and its affiliates cease to beneficially own, in the aggregate, at least 50.1% of our outstanding common stock, directors may only be removed for cause, and only by the affirmative vote of holders of at least 66 2/3% in voting power of all the then-outstanding shares of stock of the Company entitled to vote thereon, voting together as a single class. Any vacancy caused by the removal of an Apollo nominee shall only be filled by Apollo. Any vacancy on our board of directors (other than in respect of a Sponsor Director) will be filled only by the affirmative vote of a majority of the remaining directors, although less than a quorum. Any vacancy on our board of directors in respect of an Apollo Designee will be filled only by a majority of the Apollo Designees then in office or, if there are no such directors then in office, our Sponsor. Any vacancy on our board of directors in respect of a Co-Investor Designee will be filled only by a majority of the Sponsor Directors then in office or, if there are no such directors then in office, our Sponsor, as described above in “—Composition of Board of Directors; Election and Removal of Directors.” 

Doc#: US1:13557525v6

5

No Cumulative Voting 
Our Certificate of Incorporation does not provide stockholders the right to cumulate votes in the election of directors. 
Special Meetings of Stockholders 
Our Certificate of Incorporation provides that if less than 50.1% of our outstanding common stock is beneficially owned by Apollo, special meetings of the stockholders may be called only by the chairman of the board of directors or by the secretary at the direction of a majority of the directors then in office. For so long as at least 50.1% of our outstanding common stock is beneficially owned by Apollo, special meetings must be called by the secretary at the written request of the holders of a majority of the voting power of the then outstanding common stock. The business transacted at any special meeting will be limited to the proposal or proposals included in the notice of the meeting. 
 
Stockholder Action by Written Consent 
Subject to the rights of the holders of one or more series of our preferred stock then outstanding, any action required or permitted to be taken by stockholders must be effected at a duly called annual or special meeting of our stockholders; provided, that prior to the time at which Apollo ceases to beneficially own at least 50.1% of our outstanding common stock, any action required or permitted to be taken at any annual or special meeting of our stockholders may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, is signed by or on behalf of the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted and are delivered in accordance with applicable Delaware law. 
Advance Notice Requirements for Stockholder Proposals and Director Nominations 
Our Bylaws provide that stockholders who are not parties to the Stockholders Agreement and who are seeking to bring business before an annual meeting of stockholders, or to nominate candidates for election as directors at an annual meeting of stockholders, must provide timely notice thereof in writing. To be timely, a stockholder’s notice generally must be delivered to and received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary of the preceding year’s annual meeting; provided, that in the event that the date of such meeting is advanced more than 30 days prior to, or delayed by more than 60 days after, the anniversary of the preceding year’s annual meeting of our stockholders, a stockholder’s notice to be timely must be so delivered not earlier than the close of business on the 120th day prior to such meeting and not later than the close of business on the later of the 90th day prior to such meeting or, if the first public announcement of the date of such meeting is less than 100 days prior to the date of such annual meeting, the 10th day following the day on which public announcement of the date of such meeting is first made. Our Bylaws specify certain requirements as to the form and content of a stockholder’s notice. These provisions may preclude stockholders from bringing matters before an annual meeting of stockholders or from making nominations for directors at an annual meeting of stockholders. 
All the foregoing provisions of our Certificate of Incorporation and Bylaws could discourage potential acquisition proposals and could delay or prevent a change in control. These provisions are intended to enhance the likelihood of continuity and stability in the composition of the board of directors and in the policies formulated by the board of directors and to discourage certain types of transactions that may involve an actual or threatened change in control. These same provisions may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider to be in its best interest. In addition, such provisions could have the effect of discouraging others from making tender offers for our shares and, as a consequence, they also may inhibit fluctuations in the market price of our common stock that could result from actual or rumored takeover attempts. Such provisions also may have the effect of preventing changes in our management. 

Doc#: US1:13557525v6

6

Delaware Takeover Statute 
Our Certificate of Incorporation provides that we are not governed by Section 203 of the DGCL. In the absence of the provision of our Certificate of Incorporation electing not to be governed by Section 203, we would have been subject to the restrictions on business combinations between us and our subsidiaries and interested stockholders as provided in Section 203. 
However, our Certificate of Incorporation includes a provision that restricts us from engaging in any “business combination” with an “interested stockholder” for three years following the date that person becomes an interested stockholder, unless 
•    before that person became an interested stockholder, our board of directors approved the transaction in which the interested stockholder became an interested stockholder or approved the business combination; 
 
•    upon consummation of the transaction that resulted in the interested stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) stock held by directors who are also officers of our Company and by employee stock plans that do not provide employees with the right to determine confidentially whether shares held under the plan will be tendered in a tender or exchange offer; or 
•    following the transaction in which that person became an interested stockholder, the business combination is approved by our board of directors and authorized at a meeting of stockholders by the affirmative vote of the holders of at least 66 2/3% of our outstanding voting stock not owned by the interested stockholder. 
In general, a “business combination” is defined to include mergers, asset sales and other transactions resulting in financial benefit to a stockholder and an “interested stockholder” is any person who, together with affiliates and associates, is the owner of 15% or more of our outstanding voting stock or is our affiliate or associate and was the owner of 15% or more of our outstanding voting stock at any time within the three-year period immediately before the date of determination. Under our Certificate of Incorporation, an “interested stockholder” generally does not include our Sponsor and any affiliate thereof or their direct and indirect transferees. 
This provision of our Certificate of Incorporation could prohibit or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire us even though such a transaction may offer our stockholders the opportunity to sell their stock at a price above the prevailing market price. 
Amendment of Our Certificate of Incorporation 
Under Delaware law, our Certificate of Incorporation may be amended only with the affirmative vote of holders of at least a majority of the outstanding stock entitled to vote thereon. 
Notwithstanding the foregoing, our Certificate of Incorporation provides that, from and after the time Apollo ceases to beneficially own at least 50.1% of our outstanding common stock, in addition to any vote required by applicable law, our Certificate of Incorporation or our Bylaws, the affirmative vote of holders of at least 66 2/3% of all of the outstanding shares of our capital stock entitled to vote thereon, voting together as a single class is required to amend the following provisions of our Certificate of Incorporation: 
•    the provision authorizing the board of directors to designate one or more series of preferred stock and, by resolution, to provide the rights, powers and preferences, and the qualifications, limitations and restrictions thereof, of any series of preferred stock; 

Doc#: US1:13557525v6

7

•    the provisions providing for a classified board of directors, establishing the term of office of directors, relating to the removal of directors, and specifying the manner in which vacancies on the board of directors and newly created directorships may be filled; 
•    the provisions authorizing our board of directors to make, alter, amend or repeal our Bylaws; 
•    the provisions regarding the calling of special meetings and stockholder action by written consent in lieu of a meeting; 
•    the provisions eliminating, to the fullest extent permitted by law, the personal liability of a director for monetary damages to the corporation or its stockholders for breaches of fiduciary duty as a director; 
•    the provisions providing for indemnification and advance of expenses of our directors and officers; 
 
•    the provisions regarding competition and corporate opportunities; 
•    the provision specifying that, unless we consent in writing to the selection of an alternative forum, the Chancery Court of the State of Delaware, or the federal district courts of the United States of America, as applicable, will be the sole and exclusive forum for intra-corporate disputes; 
•    the provisions regarding entering into business combinations with interested stockholders; 
•    the provision requiring that, from and after the time Apollo ceases to beneficially own at least 50.1% in voting power of our outstanding common stock, amendments to specified provisions of our Certificate of Incorporation require the affirmative vote of 66 2/3% in voting power of our outstanding stock, voting as a single class; and 
•    the provision requiring that, from and after the time Apollo ceases to beneficially own at least 50.1% of our outstanding common stock, amendments by the stockholders to our Bylaws require the affirmative vote of 66 2/3% in voting power of our outstanding stock, voting as a single class. 
Amendment of Our Bylaws 
Our Bylaws provide that they can be amended by the vote of the holders of shares constituting a majority of the voting power or by the vote of a majority of the board of directors. However, our Certificate of Incorporation provides that, from and after the time Apollo ceases to beneficially own at least 50.1% in voting power of our outstanding common stock, in addition to any vote required under our Certificate of Incorporation, the affirmative vote of the holders of at least 66 2/3% of the voting power of the outstanding shares of stock entitled to vote thereon, voting as a single class, is required for the stockholders to alter, amend or repeal any provision of our Bylaws or to adopt any provision inconsistent therewith. 
The provisions of the DGCL, our amended certificate and our amended bylaws could have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These provisions may also have the effect of preventing changes in our management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests. 

Doc#: US1:13557525v6

8

Exclusive Forum Selection 
Unless we consent in writing to the selection of an alternative forum, the Chancery Court of the State of Delaware will, to the fullest extent permitted by law, be the sole and exclusive forum for: 
•    any derivative action or proceeding brought on our behalf; 
•    any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, or stockholders; 
•    any action asserting a claim arising pursuant to any provision of the DGCL or of our Certificate of Incorporation or our Bylaws; or 
•    any action asserting a claim against us or any of our directors or officers governed by the internal affairs doctrine. 
In addition, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act.
This exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. To the extent that any such claims may be based upon federal law claims, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock will be deemed to have notice of and, to the fullest extent permitted by law, to have consented to the provisions described in this paragraph. Our stockholders will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder as a result of our exclusive forum provisions. However, the enforceability of similar forum provisions in other companies’ certificates of incorporation have been challenged in legal proceedings, and it is possible that a court could find these types of provisions to be unenforceable.
Listing 
Our shares of common stock are listed on the New York Stock Exchange under the symbol “ADT.” We do not intend to list our Class B common stock on any national securities exchange.  
Transfer Agent and Registrar 
The transfer agent and registrar for our common stock and Class B common stock is American Stock Transfer & Trust Company, LLC.

Doc#: US1:13557525v6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}]]